ABSTRACT. An association between favism (a hemolytic reaction to consumption of fava beans), glucose-6-phosphate dehydrogenase deficiency (G6PD -) and acid phosphatase locus 1 (ACP 1 ) phenotypes has been reported; the frequency of carriers of the p a and p c ACP 1 alleles was found to be significantly higher in G6PD
-individuals showing favism than in the general population. Here, we investigated the hypothesis that favism is caused by toxic Vicia faba substances, which in some ACP 1 phenotypes cause increased phosphorylation and consequently increased glycolysis, with strong reduction in reduced glutathione production, resulting in hemolysis. It has been demonstrated that ACP 1 f isoforms have physiological functions different from those of s isoforms and are responsible for most of the phosphatase activity, in addition to being less stable in the presence of oxidizing molecules. Thus, the C, CA and A phenotypes, characterized by lower concentrations of f isoforms, could be more susceptible to damage by oxidative events compared to the other phenotypes. To test this hypothesis, the (f+s) enzymatic activity of different ACP 1 phenotypes with and without added V. faba extract was analyzed. Enzymatic activities of ACP 1 A, -CA, -C groups (low activity) and -B,
INTRODUCTION
An association between hemolytic favism and acid phosphatase locus 1 (ACP 1 ) genotype was described over thirty years ago (Bottini et al., 1971a) . Upon ingesting Vicia faba beans, approximately 30% of the subjects deficient in glucose-6-phosphate dehydrogenase (G6PD -) (EC 1.1.1.49) underwent a hemolytic crisis. The susceptibility to favism was shown to be correlated to the ACP 1 genotype in the order BB < AB,BC < AA,AC. At the time, it was not possible to propose a satisfactory explanatory mechanism.
More recently, two hypotheses have been formulated to explain the association between favism, G6PD -deficiency and ACP 1 alleles. Starting with the notion that reduced levels of reduced glutathione (GSH) are responsible for red blood cell lysis (Beutler, 1969; Johnson et al., 1994) , the hypotheses differ in the mechanism leading to a reduction of GSH levels.
1) The ACP 1 enzyme (EC 3.1.3.2) dephosphorylates flavin mononucleotide to riboflavin (Fuchs et al., 1992) . By modulating the cellular concentration of flavin mononucleotide and thereby flavin adenine dinucleotide, ACP 1 may influence the activity of glutathione reductase (EC 1.8.1.7), where flavin adenine dinucleotide acts as a coenzyme. This hypothesis, however, does not fully explain the biochemical mechanism because the ACP 1 genotypic order of susceptibility to favism BB < AB,BC < AA,AC is different from that based on enzymatic activity, which is AA < AB < BB,AC < BC.
2) An alternative biochemical basis for favism was also suggested (Dissing, 1993; Bottini et al., 1997) . ACP 1 isoforms were shown to dephosphorylate band 3 protein (B3P) (Boivin and Galand, 1986) . When one or two tyrosines in the amino terminal portion of this protein are phosphorylated, binding of glycolytic enzymes such as aldolase (EC 4.1.2.13), phosphofructokinase (EC 2.7.1.11) and glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12) are inhibited.
Thus, ACP 1 would modulate the glycolytic activity through its phosphatase activity, which determines the phosphorylation level of B3P. A decreased phosphatase activity leading to enhanced phosphorylation of B3P would lead to enhanced glycolysis, causing a decreased nicotinamide adenine dinucleotide phosphate (NADPH) level, which would ultimately block GSH production and cause red blood cell lysis. Each ACP 1 allele encodes a different amount of the f and s isoforms (Dissing, 1993) . It was suggested that the inhibition of ACP 1 f isoforms, caused by toxic substances contained in V. faba, could cause damage in the C, CA and A phenotypes, constitutionally with lower concentration of f isoforms, more than in the other phenotypes (Bottini et al., 1997) .
To throw light on the mechanism leading to favism, a V. faba extract (Vfe) was pre-pared, its oxidation capacity on GSH tested and the enzymatic activity associated with 119 ACP 1 phenotypes was determined in the absence and presence of Vfe.
MATERIAL AND METHODS

Subjetcs
A total of 119 whole blood samples from anonymous individuals were obtained from the Macerata Hospital Transfusion Center, Macerata, Italy. Ethics approval and patient consent statements were not required in this case.
Vicia faba extract
Vfe was prepared as described elsewhere (Bottini et al., 1970; Beutler, 1975) with slight modifications. A total of 450 g V. faba beans were homogenized and added to an equal weight of water and a chloroform-methanol mix (chloroform-methanol, 1:1). The resulting mixture was stirred for 20 h at room temperature. The liquid phase was then separated from the solid residue by two sequential filtrations on a filter funnel and Whatman 3MM paper. The liquid phase was separated using a separation funnel into an organic phase that was discarded, and an aqueous phase, which was concentrated by roto-evaporation at 37°C until a solid residue, was obtained. This was resuspended in distilled water. After clarification by centrifugation at 257,000 g for 1 h, the resulting supernatant (50 mL) was used to carry out glutathione oxidation experiments and ACP 1 activity assays.
GSH assay
To evaluate the oxidative properties of Vfe, GSH oxidation was determined as described by Beutler (1975) with slight modifications (Figure 1) .
The oxidative effect of V. faba bean extract was measured using 5,5' dithiobis-2-nitrobenzoic acid (DTNB), which reacts with GSH to generate glutathione disulfide and 2-nitro-5-thiobenzoic acid, a yellow-colored product. The GSH concentration was determined by measurement of the absorbance at 410 nm. The reaction mixtures, in a final volume of 5 mL, containing 0.1 M phosphate buffer, pH 7.4, 0.02 M EDTA, and 0.005 M GSH, with and without V. faba bean extract, were incubated at 37°C. After the incubation time, an aliquot of the mixture was added to DTNB and the absorbance was measured against the blank.
ACP 1 genotyping
DNA was extracted from whole blood samples using standard procedures. ACP 1 genotyping of single nucleotide polymorphisms characterized by a silent C-T transition at codon 41 within exon 3 and an A-G transition at codon 105 within exon 6 was performed by restriction fragment length polymorphism (RFLP) and polymerase chain reaction (PCR), essentially as described elsewhere (Bottini et al., 2002) . Following PCR amplification of the regions of interest, the resulting 341-and 299-bp amplicons were digested with restriction endonucleases CfoI and TaqI, respectively, and analyzed on 1.8% agarose gels. CfoI digestion of the 341-bp exon 3 amplicon yielded 2 fragments of 255 and 86 bp for the ACP 1 *A and ACP 1 *B alleles, while the ACP 1 *C allele was not cut. Similarly, the TaqI digested a 299-bp amplicon and generated 2 fragments of 100 and 199 bp for the ACP 1 *A allele, but not for the *B and *C alleles. Thus, comparative analyses of the two RFLPs allowed us to determine the two haplotypes and from that the ACP 1 genotypes.
The ACP 1 genotypic distribution determined in our sample population was: BB = 41; BA = 42; CB = 15; AA = 11; CA = 9; CC = 1. The distribution was in Hardy-Weinberg equi-
The distribution was in Hardy-Weinberg equilibrium (P 3d.f. = 0.8).
ACP 1 enzymatic activity assay
ACP 1 activity, with and without Vfe, was performed as reported previously by us (Lucarini et al., 1989) . ACP 1 activity was determined for each sample with and without Vfe (50 µL) in a 500-µL reaction mixture. Total protein was determined for each sample with the Bradford method (Bradford, 1976) . A unit of activity was expressed as 1 µmol p-nitrophenol produced per minute per gram protein at 37°C.
Statistical analysis
The Student t-test and analysis of variance were performed using the SPSS program (Nie et al., 1975) . 
RESULTS
The results obtained are presented in Table 1 , which lists the total activity (f+s) of the different ACP 1 phenotypes found in the absence and presence of Vfe. We also reported the f isoforms' mean activity of ACP 1 phenotypes calculated according to Dissing et al. (1993 Values assuming that the activity of both f and s isoforms is reduced by the same percentage.
As seen in Table 1 ]. In the absence of Vfe, the differences between enzymatic activities associated with ACP 1 A, -CA, and -C phenotypes (mean = 19.46, SD = 8.04) and those associated with -B, -BA, -CB phenotypes (mean = 23.88, SD = 9.04) show a statistically significant albeit minor difference (d.f. = 1, F = 4.007, P = 0.048). On the other hand, in the presence of Vfe, the difference between the two phenotype groups (mean = 12.04, SD = 5.65 and mean = 16.71, SD = 6.44, respectively) reaches a highly significant level (d.f. = 1, F = 9.466, P = 0.003). In particular, assuming that the f and s isoform activities are reduced by the same proportion, the distribution of phosphatase activity values associated with f isoforms in the presence of Vfe (that is: Bf = 12.34; Af Bf = 9.95; Af = 6.42; Bf Cf = 9.57; Af Cf = 3.64; Cf = 5.00) shows that the activity of isoform f of ACP 1 reaches much lower values in C, CA, and A phenotypes than in B, BA, BC phenotypes.
DISCUSSION
ACP 1 enzymatic activity is determined by two types of isoforms (f and s) (Dissing, 1993) , and each ACP 1 phenotype expresses different amounts of the f and s isoforms. These two isoforms have different biochemical properties. In fact, when the effect of oxidizing agents and heat treatment on the electrophoretic patterns of hemolysates was analyzed, the ACP 1 s isoforms were found to be endowed with a higher stability compared to the f isoforms (Luffman and Harris, 1967; Fisher and Harris, 1971) and to be more stable under the action of oxidized glutathione and ACP 1 genetic polymorphism and favism acetylphenylhydrazine (Bottini et al., 1971b) . Furthermore, results obtained with the pure Af, As, Bf, Bs, Cf, and Cs isoforms confirmed that s isoforms are more stable than f isoforms vis-à-vis urea denaturation and heat treatment (Fisher and Harris, 1971; White and Butterworth, 1971) .
These findings, together with the different behavior of f and s isoforms towards inhibitors and activators , strongly suggest that the two isoforms, which are expressed at the same time in different tissues (Fujimoto et al., 1988) , perform different biological functions in vivo (Dissing and Svensmark, 1990; Stefani et al., 1993) and that f isoforms are the main ones responsible for phosphatase activity of the ACP 1 gene, rather than s isoforms. Furthermore, it has been demonstrated (Stefani et al., 1993 ) that the 5-16 phosphotyrosines present in the N-terminal peptide of human B3P are more efficiently dephosphorylated by f isoforms than by s isoforms [K m (mM) 1.4→0.4; V max (µmol·min -1 ·mg -1 ) 68→10.5]. In light of that mentioned above, our data show that f isoforms, which are more sensitive to oxidative damage compared to s isoforms (Luffman and Harris, 1967; Fisher and Harris, 1971; Bottini et al., 1971b) , are likely to undergo inhibition by Vfe more than that reported in the last column of Table 1 , where the f activity is calculated reducing it by the same proportion of s as reported by Dissing et al. (1993) and where the much higher inhibition of f isoforms compared to s isoforms is not taken into consideration. Therefore, considering that the values of f isoform activities in the presence of Vfe will be certainly lower than those that we have calculated here (i.e., AA = 6.42; CA = 3.64; CC = 5.00), the real f activity associated with ACP 1 AA, ACP 1 CA, ACP 1 CC genotypes will reach extremely low values. These phenotypes could have an increased phosphorylation of B3P tyrosines, an increased glycolysis, a consequent reduction of glucose-6-phosphate, and a further loss of NADPH in G6PD -subjects. In turn, this would be associated with levels of GSH so low as to be harmful to erythrocyte integrity.
